Significance: For breast cancer patients, the extent of regional lymph node (LN) metastasis influences the decision to remove all axillary LNs. Metastases are currently identified and classified with visual analysis of a few thin tissue sections with conventional histology that may underrepresent the extent of metastases.
Aim: We sought to enable nondestructive three-dimensional (3D) pathology of human axillary LNs and to develop a practical workflow for LN staging with our method. We also sought to evaluate whether 3D pathology improves staging accuracy in comparison to two-dimensional (2D) histology.
Approach: We developed a method to fluorescently stain and optically clear LN specimens for comprehensive imaging with multiresolution open-top light-sheet microscopy. We present an efficient imaging and data-processing workflow for rapid evaluation of H&E-like datasets in 3D, with low-resolution screening to identify potential metastases followed by high-resolution localized imaging to confirm malignancy.
Results: We simulate LN staging with 3D and 2D pathology datasets from 10 metastatic nodes, showing that 2D pathology consistently underestimates metastasis size, including instances in which 3D pathology would lead to upstaging of the metastasis with important implications on clinical treatment.
Conclusions: Our 3D pathology method may improve clinical management for breast cancer patients by improving staging accuracy of LN metastases.
Glandular architecture is currently the basis for the Gleason grading of prostate biopsies. To visualize and computationally analyze glandular features in large 3D pathology datasets, we developed an annotation-free segmentation method for 3D prostate glands that relies upon synthetic 3D immunofluorescence (IF) enabled by generative adversarial networks. By using a fluorescent analog of H and E (cheap and fast stain) as an input, our strategy allows for accurate glandular segmentation that does not rely upon subjective and tedious human annotations or slow and expensive 3D immunolabeling. We aim to demonstrate that this 3D segmentation will enable improved prostate cancer prognostication.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.